Corporate Profile

At Sumitomo Pharma, we are focusing our efforts on the research and development of innovative and useful pharmaceuticals as well as healthcare solutions, in the relentless pursuit of our mission: To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide.

Basic Information

Name Sumitomo Pharma Co., Ltd.
Establishment May 14, 1897
Representative Hiroshi Nomura, Representative Director, President and CEO
Capitalization 22.4 billion yen (as of March 31, 2024)
Fiscal year April 1 to March 31
Employees 2,908 (4,980: consolidated)(as of March 31, 2024)
Business(consolidated) Manufacturing and sales of pharmaceuticals and others
Osaka Head Office 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, Osaka 541-0045, Japan
Main number´╝Ü+81-6-6203-5321
Tokyo Head Office Tokyo Nihombashi Tower, 2-7-1, Nihonbashi, Chuo-ku, Tokyo 103-6012, Japan
Main number: +81-3-5205-3720

Company introduction movie

Company introduction

This movie briefly chronicles the challenges we have taken on and the stance we have taken along the way, starting with our founders’ aspiration: "Let's build the perfect pharmaceutical factory to serve everyday people all across society."

Continuing to challenge ourselves to support a healthy future for people
(0:04:17)

Sumitomo Pharma’s roots

This movie is an introduction to the roots of Sumitomo Pharma, which was founded in the pharmaceutical district of Doshomachi, Osaka in May 1897, and ever since then has continued to develop for more than 100 years.
In this movie, we share our founders’ spirit, the history of Sumitomo, and the challenges we have taken on to date, together with sceneries of Doshomachi and other historic records.

Sumitomo Pharma’s roots (in Japanese only)
(00:06:07)

Official YouTube channel

You will find disease awareness videos, videos introducing Sumitomo Pharma, and more on our official YouTube channel.

Official Facebook page

You will find information about our research collaborations, in-licensing activities, acquisitions, and more on our official Facebook page.

Contact Us

For inquiries, please click here.